CONSIDERATIONS TO KNOW ABOUT ABBV-744 BRD4 INHIBITOR CANCER THERAPY EFFICACY

In Segment A, contributors will get diverse doses and schedules of oral ABBV-744 pill to discover Protected dosing regimen. Supplemental members is going to be enrolled on the identified monotherapy dosign routine. In Section B, participants will receive oral ruxolitinib and ABBV-744 will be specified as "insert-on" therapy. In Segment C, members w